维普中文期刊产品整合服务
19篇 您的检索式:作者名="HEXNER E"
    题名 作者 年代 出处 被引量
1Open-label study of oral CEP-701 (lestaurtinib) in patients with polycythaemia vera or essential thrombocythaemia with JAK2-V617F mutation 显示文摘Hexner E Roboz G Hoffman R 2014Br J Haematol2014,164,1:1
2Host-reactive CD8^+ memory stem cells in graft-versus-host diseasesw显示文摘ZHANG Y JOE G HEXNER E 2005Nat Med2005,11,12:1
3An open-label study of CEP-701 in patients with JAK2 V617F-positive PV and ET: update of 39 enrolled patients 显示文摘Molitemo AR Hexner E Roboz GJ 2009Blood2009,114,22:1
4Host-reactive CD8 + memory stem cells in graft-versus-host disease 显示文摘Zhang Y Joe G Hexner E 2005Nat Med2005,11,12:1
5Molecular-based classification of acute myeloid leukemia and its role in directing rational therapy: personalized medicine for profoundly promiscuous proliferations 显示文摘Wertheim GB Hexner E Bagg A 2012Mol Diagn Ther2012,16,6:1
6Alloreactive memory T cells are responsible for the persistence of graft-versus-host diseasem显示文摘Zhang Y Joe G Hexner E 2005J Immunol2005,,:1
7JAK2 V617F:implications for thrombosis in myeloproliferative diseases显示文摘Hexner E O 2007Curr Opin Hematol2007,14,5:1
8Host-reactive CD8 + memorystem cells in graft-versus-host disease 显示文摘Zhang Y Joe G Hexner E 2005Nat Med2005,11,:1
9Lestaur-tinib(CEP701)is a JAK2 inhibitor that suppressesJAK2/STAT5 signaling and the proliferation of primaryerythroid cells from patients with myeloproliferative dis-orders显示文摘HEXNER E 0 SERDIK0FF C’JAN M 2008Blood2008,111,12:1
10Open-label study of oral CEP-701 (lestaurtinib) in patients with polycythaemia vera or essential thrombocythaenaia with JAK2-V617F mutation显示文摘Hexner E Roboz G Hoffman R 2014Br J Haemato12014,164,1:1
11Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease显示文摘Zhang Y Joe G Hexner E 2005J Immunol2005,174,5:1
12Host-reactive CD8^+ memory stem cells in graft-versus-host-disease显示文摘Zhang Y Joe G Hexner E 2005Nat Med2005,11,12:1
13Lestau- rtinib (CEPT01) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative dis- orders显示文摘HEXNER E O SERDIKOFF C JAN M 2008Blood2008,111,12:1
14Host-reactive CD8^+ memory stem cells in graft-versus-host disease显示文摘Zhang Y Joe G Hexner E 2005Nat Med2005,11,12:1
15Lestaurtinib(CEP701)is a JAK2inhibitor that suppresses JAK2/STAT5signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders显示文摘HEXNER E O SERDIKOFF C JAN M 2008Blood2008,111,:1
16Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease显示文摘Zhang Y Joe G Hexner E 0,,:1
17Lestaurtinib ( CEP701 ) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders 显示文摘Hexner E O Serdikoff C Jan M 2008Blood2008,111,12:1
18Molecular-based classification of acute myeloid leukemia and its role in directing rational therapy:personalized medicine for profoundly promiscuous proliferations显示文摘Wertheim GB Hexner E Bagg A 2012Mol Diagn Ther2012,16,6:1
19Host-reactive CD8 + memorystem cells in graft-versus-host disease 显示文摘Zhang Y Joe G Hexner E 2005Nat Med2005,11,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费